BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9398701)

  • 1. Effects of luteinizing hormone-releasing hormone analog-induced pubertal delay in growth hormone (GH)-deficient children treated with GH: preliminary results.
    Cassorla F; Mericq V; Eggers M; Avila A; García C; Fuentes A; Rose SR; Cutler GB
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3989-92. PubMed ID: 9398701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial.
    Mericq MV; Eggers M; Avila A; Cutler GB; Cassorla F
    J Clin Endocrinol Metab; 2000 Feb; 85(2):569-73. PubMed ID: 10690857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of treatment with GH alone or in combination with LHRH analog on bone mineral density in pubertal GH-deficient patients.
    Mericq V; Gajardo H; Eggers M; Avila A; Cassorla F
    J Clin Endocrinol Metab; 2002 Jan; 87(1):84-9. PubMed ID: 11788628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of puberty in growth hormone deficient children.
    Saggese G; Federico G; Barsanti S
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():329-34. PubMed ID: 10698597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of deslorelin-induced pubertal delay on the growth of adolescents with short stature and normally timed puberty: preliminary results.
    Municchi G; Rose SR; Pescovitz OH; Barnes KM; Cassorla FG; Cutler GB
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1334-9. PubMed ID: 8077329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone (GH)-treated GH-deficient children.
    Hibi I; Tanaka T; Tanae A; Kagawa J; Hashimoto N; Yoshizawa A; Shizume K
    J Clin Endocrinol Metab; 1989 Aug; 69(2):221-6. PubMed ID: 2526818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study.
    Saggese G; Federico G; Barsanti S; Fiore L
    J Clin Endocrinol Metab; 2001 May; 86(5):1900-4. PubMed ID: 11344181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa.
    van der Steen M; Lem AJ; van der Kaay DC; Hokken-Koèelega AC
    J Clin Endocrinol Metab; 2016 May; 101(5):2005-12. PubMed ID: 26964733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia.
    Lin-Su K; Vogiatzi MG; Marshall I; Harbison MD; Macapagal MC; Betensky B; Tansil S; New MI
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3318-25. PubMed ID: 15797962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
    Quintos JB; Vogiatzi MG; Harbison MD; New MI
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty.
    Mansfield MJ; Rudlin CR; Crigler JF; Karol KA; Crawford JD; Boepple PA; Crowley WF
    J Clin Endocrinol Metab; 1988 Jan; 66(1):3-9. PubMed ID: 2961786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogue.
    Tanaka T; Satoh M; Yasunaga T; Horikawa R; Tanae A; Katsumata N; Tachibana K; Nose O; Hibi I
    Acta Paediatr Suppl; 1999 Feb; 88(428):85-8. PubMed ID: 10102060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
    Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M
    J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
    Lem AJ; van der Kaay DC; de Ridder MA; Bakker-van Waarde WM; van der Hulst FJ; Mulder JC; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Sulkers EJ; Westerlaken C; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4096-105. PubMed ID: 22904179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined GH and LHRH analog treatment in short children.
    Tanaka T; Satoh M; Hibi I
    Endocr J; 1996 Oct; 43 Suppl():S13-7. PubMed ID: 9076337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.